Abstract
A great part of human genetics research is carried out collecting data and building large databases of biological samples that are in a non-anonymous format. These constitute a valuable resource for future research. The construction of such databases and tissue banks facilitates important scientific progress. However, biobanks have been recognized as ethically problematic because they contain thousands of data that could expose individuals and populations to discrimination, stigmatization and psychological stress if misused. Informed consent is regarded as a cornerstone in the protection of personal autonomy in research involving human subjects. Yet in recent years this fundamental concept has been overwhelmed by the genomic revolution. From a general overview of international literature, it seems evident that informed consent issues have come into sharp focus, in particular in relation to the twin issues of time extension (blanket versus specific/repeated consent) and personal extension (group consent). After an introduction on obtaining informed consent in the context of genetic research, this paper addresses the apparent lack of a single, universal model of obtaining informed consent among populations involved in genetic research and it argues for the need to develop an ethical framework tailored to the specific features of each project. In order to support this theory of contextualizing, the case of a private biotechnology company, SharDNA is presented. The present paper explores the management of its biobank, developed from a genetic research project carried out on isolated populations living on the Italian island of Sardinia. In particular, the paper highlights how the company is tackling the problem of informed consent and other ethical requirements for genetic research, such as the respect of individual privacy, the population approach and the existing Italian legal regulatory framework.
Similar content being viewed by others
References
Angius A., et al. (2001) Archival, Demographic and Genetic Studies Define a Sardinian Sub-isolate as a Suitable Model for Mapping Complex Traits. Human Genetics 109(2): 198–209
Angius A., et al. (2002) A New Essential Hypertension Susceptibility Locus on Chromosome 2p24-p25, Detected by Genome Widesearch. American Journal of Human Genetics 71(4): 893–905
Annas G. (2000) Rules for Research on Human Genetic Variation – Lessons from Iceland. New England Journal of Medicine 342(24):1830–1833
Árnason V. (2004) Coding and Consent: Moral Challenges of the Database Project in Iceland. Bioethics 18(1): 27–49
Austin M.A., et al. (2003) Genebanks: A Comparison of Eight Proposed International Genetic Databases. Community Genetics 6(1): 37–45
Barker J.H. (2003) Common-pool Resources and Population Genomics in Iceland, Estonia, and Tonga. Medicine, Health Care and Philosophy, 6(2): 133–144
Berg K. (2001) DNA Sampling and Banking in Clinical Genetics and Genetic Research. New Genetics and Society, 20(1): 59–68
Caulfield T., et al. (2003) DNA Databanks and Consent: A Suggested Policy Option Involving an Authorization Model. BCM Medical Ethics 4:1
Chadwick R. (1999) The Icelandic Database: Do Modern Times Need Modern Sagas? British Medical Journal 319:441–444
Chadwick R., Berg K. (2001) Solidarity and Equity: New Ethical Frameworks for Genetic Database. Nature Review Genetics 2(4): 318–321
Emanuel E.J., et al. (2000) What Makes Clinical Research Ethical? JAMA 283(20): 2701–2711
Faden R., Beauchamp T.L. (1986) A History and Theory of Informed Consent. Oxford University Press, New York
Fernandez C.V., et al. (2003) Informing Study Participants of Research Results: An Ethical Imperative. IRB: Ethics and Human Research 25(3): 12–19
Foster M.W., et al: (1998) A Model Agreement for Genetic Research in Socially Identifiable Populations. American Journal of Human Genetics 63(3): 682–685
Gianfrancesco F., et al. (2003) Identification of a Novel Gene and a Common Variant Associated with Uric Acid Nephrolithiasis in a Sardinian Genetic Isolate. American Journal of Human Genetics 72(6): 1479–1491
Godard B., et al. (2004) Strategies for Consulting with the Community: The Cases of Four Large-Scale Genetic Databases. Science and Engineering Ethics 10(3): 457–477
Gostin L.O., Hodge J.G., 1999 Genetic Privacy and the Law: An End to Genetics Exceptionalism. Jurimetrics 40(1): 21–58
Greely H.T. (1999) Breaking the Stalemate: A Prospective Regulatory Framework for Unforeseen Research Uses of Human Tissue Samples and Health Information. Wake Forest Law Review 34:737–766
Greely H.T. (2000) Iceland’s Plan for Genomic Research: Facts and Implications. Jurimetrics 40(1): 153–191
Hirtzlin I., et al. (2003) An Empirical Survey on Biobanking of Human Genetic Material and Data in Six EU Countries. European Journal of Human Genetics 11(6): 475–488
Juengst E.T. (1998) Groups as Gatekeepers to Genomic Research: Conceptually Confusing, Morally Hazardous and Practically Useless. Kennedy Institute of Ethics Journal 8:2
Juengst E.T. (2000) What ‹Community Review’ Can and Cannot Do. Journal of Law, Medicine & Ethics 28(1): 52–54
Lawrence, W.W.: 2002, ‹Learning from Experience. Privacy and the Secondary Use of Data in Health Research’, ed. by The Nuffield Trust.
Manasco P.K. (2005) Ethical and Legal Aspects of Applied Genomic Technologies: Practical Solutions. Current Molecular Medicine 5(1): 23–28
Merz J.F., et al. (2002) Protecting Subjects’ Interests in Genetics Research. American Journal of Human Genetics 70(4): 965–971
Mitchell G.R., Happe K. (2001a) Defining the Subject of Consent in DNA Research. Journal of Medical Humanities 22(1): 41–53
Mitchell G.R., Happe K. (2001b) Informed Consent after the Human Genome Project. Rhetoric and Public Affairs 4(3): 375–406
Murray T. (1997) Genetic Secrets and Future Diaries: Is Genetic Information Different from Other Medical Information? In: Rothstein (eds) Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era. Yale University Press, New Haven, pp. 60–73
O’Neill O. (2003) Some Limits of Informed Consent. Journal of Medical Ethics 29: 4–7
Racine E. (2003) Discourse Ethics as an Ethics of Responsibility: Comparison and Evaluation of Citizen Involvement in Population Genomics. Journal of Law, Medicine & Ethics 31(3): 377–389
Reilly P.R. (1998) Rethinking Risks to Human Subjects in Genetics Research. American Journal of Human Genetics 63(3): 682–685
Robertson J.A. (1999) Privacy Issues in Second Stage Genomics. Jurimetrics 40(1): 59–76
Roche, P.A. and G.J. Annas: 2001, ‹Protecting Genetic Privacy’, Nature Review Genetics 2(3)
Sharp R.R., Foster M.W. (2000) Involving Study Populations in the Review of Genetic Research. Journal of Law, Medicine & Ethics 28(1): 41–51
Struewing J., et al. (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New England Journal Medicine 336: 1401–1408
Wendler D., Emanuel E. (2002) The Debate over Research on Stored Biological Samples: What do Sources Think? Archival of Internal Medicine 162(13): 1457–1462
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Artizzu, F. The informed consent aftermath of the genetic revolution. An Italian example of implementation. Med Health Care Philos 11, 181–190 (2008). https://doi.org/10.1007/s11019-007-9086-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11019-007-9086-y